© 2012 Landes Bioscience. Do not distribute. Radiosensitization induced by the anti-epidermal growth factor receptor monoclonal antibodies cetuximab and nimotuzumab in A431 cells

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Nimotuzumab for pediatric diffuse intrinsic pontine gliomas

  2011cited by this paper
• Bivalent binding by intermediate affinity of nimotuzumab: A contribution to explain antibody clinical profile

  2011cited by this paper
• Histone γH2AX and Poly(ADP-Ribose) as Clinical Pharmacodynamic Biomarkers

  2010cited by this paper
• Induction of γ-H2AX foci in human exfoliated buccal cells after in vitro exposure to ionising radiation

  2010cited by this paper
• Epidermal growth factor receptor in glioma: signal transduction, neuropathology, imaging, and radioresistance.

  2010cited by this paper
• Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer.

  2009cited by this paper
• Enhancement of the antitumor activity of ionising radiation by nimotuzumab, a humanised monoclonal antibody to the epidermal growth factor receptor, in non-small cell lung cancer cell lines of differing epidermal growth factor receptor status

  2008cited by this paper
• γH2AX and cancer

  2008cited by this paper
• The buccal cytome and micronucleus frequency is substantially altered in Down's syndrome and normal ageing compared to young healthy controls.

  2008cited by this paper
• The impact of a negligent G2/M checkpoint on genomic instability and cancer induction

  2007cited by this paper
• A Phase 1 Escalating Single-Dose and Weekly Fixed-Dose Study of Cetuximab: Pharmacokinetic and Pharmacodynamic Rationale for Dosing

  2007cited by this paper
• Mammalian single-strand break repair: mechanisms and links with chromatin.

  2007cited by this paper
• Chromosome breakage after G2 checkpoint release

  2007cited by this paper
• Integration of EGFR inhibitors with radiochemotherapy

  2006cited by this paper
• Role of non-homologous end joining (NHEJ) in maintaining genomic integrity.

  2006cited by this paper
• Nimotuzumab: evidence of clinical benefit without rash.

  2005cited by this paper
• Radiation-induced Epidermal Growth Factor Receptor Nuclear Import Is Linked to Activation of DNA-dependent Protein Kinase*

  2005cited by this paper
• Inhibition of radiation-induced EGFR nuclear import by C225 (Cetuximab) suppresses DNA-PK activity.

  2005cited by this paper
• Mechanism of DNA double-strand break repair by non-homologous end joining.

  2005cited by this paper
• Use of the humanized anti-epidermal growth factor receptor monoclonal antibody h-R3 in combination with radiotherapy in the treatment of locally advanced head and neck cancer patients.

  2004cited by this paper
• Homologous recombination: down to the wire.

  2004cited by this paper
• Role of DNA-PK in the cellular response to DNA double-strand breaks.

  2004cited by this paper
• Expression of phosphorylated histone H2AX as a surrogate of cell killing by drugs that create DNA double-strand breaks.

  2003cited by this paper
• Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.

  2002cited by this paper
• Physical Interaction between Epidermal Growth Factor Receptor and DNA-dependent Protein Kinase in Mammalian Cells*

  1998cited by this paper
• The effect of ionizing radiation on signal transduction: antibodies to EGF receptor sensitize A431 cells to radiation.

  1996cited by this paper

• Reactive oxygen species-inducing titanium peroxide nanoparticles as promising radiosensitizers for eliminating pancreatic cancer stem cells

  2022cites this paper
• Application of Radiosensitizers in Cancer Radiotherapy

  2021cites this paper
• Nimotuzuma restrains proliferation and induces apoptosis in human osteosarcoma cells by regulation of EGFR/PI3K/AKT signal pathway

  2019cites this paper
• Iron-oxide nanoparticles target intracellular HSP90 to induce tumor radio-sensitization.

  2019cites this paper
• Lapatinib, a Dual Inhibitor of Epidermal Growth Factor Receptor (EGFR) and HER-2, Enhances Radiosensitivity in Mouse Bladder Tumor Line-2 (MBT-2) Cells In Vitro and In Vivo

  2018cites this paper
• Inhibition of GRP78 abrogates radioresistance in oropharyngeal carcinoma cells after EGFR inhibition by cetuximab

  2017cites this paper
• Hapten-Anti-Hapten Technique for Two-Color IHC Detection of Phosphorylated EGFR and H2AX Using Primary Antibodies Raised in the Same Host Species.

  2017cites this paper
• Effects of epidermal growth factor receptor kinase inhibition on radiation response in canine osteosarcoma cells

  2016cites this paper
• Monoclonal antibody therapy in Non-Small Cell Lung Cancer

  2014cites this paper
• Efectos del bloqueo del sistema EGF/EGFR sobre la cicatrización de las heridas en pacientes oncológicos

  2014cites this paper
• Radiation Oncology In Vitro: Trends to Improve Radiotherapy through Molecular Targets

  2014cites this paper
• EGFR-targeted plasmonic magnetic nanoparticles suppress lung tumor growth by abrogating G2/M cell-cycle arrest and inducing DNA damage

  2014cites this paper
• Early investigational drugs that target epidermal growth factor receptors for the treatment of head and neck cancer

  2014cites this paper
• Nimotuzumab as a radiosensitizing agent in the treatment of high grade glioma: challenges and opportunities

  2013cites this paper
• Nimotuzumab as a radiosensitizing agent in the treatment of high grade glioma: challenges and opportunities

  2013cites this paper
• Nimotuzumab as a radiosensitizing agent in the treatment of high grade glioma: challenges and opportunities

  2013cites this paper
• Anti-Epidermal Growth Factor/Epidermal Growth Factor Receptor Therapeutic Anti-cancer Drugs and the Wound Healing Process

  2012cites this paper